It was reported that a m.Blue (#fx851t) was implanted during a procedure performed on (b)(6) 2023.According to the complainant, the valve showed an under-drainage, slowed outflow ex vivo.The patient had another valve implanted during the operation on (b)(6) 2023.The complainant device has returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 68 years.Weight: 90 kilograms.Height: 165 centimeters.Gender: female.
|
Visual inspection: during the investigation, no significant deformations or damage of the valve was determined.Permeability test: a permeability test has shown that the m.Blue is permeable and that the lumbalcatheter has a blockage.The catheter was tested for permeability in sections and organic particles were flushed out.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in both the horizontal as well as the vertical positions.The results show that the m.Blue operates within the accepted tolerance in the horizontal position, but not in the vertical position.An accelerated outflow of m.Blue could be determined.Adjustment test: the m.Blue valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Results: based on our examination results, we can detect organic particles in the catheter.The particles may have led to the malfunction complained about, and the m.Blue works as expected.Deposits caused by natural substances in the body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of proteins can impair the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|